Exelon (EXC) Financials

$43.91 +0.24 (+0.55%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$43.98 +0.07 (+0.15%)

As of 05/27/2025 07:01 PM Eastern

Annual Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	2,460	2,328	2,170	1,706	1,963	2,936	2,005	3,779	1,121	1,697
Consolidated Net Income / (Loss)	2,460	2,328	2,171	1,829	1,954	3,028	2,079	3,869	1,196	1,669
Net Income / (Loss) Continuing Operations	2,460	2,328	2,054	1,616	1,099	3,028	2,079	3,869	32,514	0.00
Total Pre-Tax Income	2,667	2,702	2,403	1,654	1,092	3,985	2,225	3,775	1,973	3,330
Total Operating Income	4,319	4,023	3,315	2,682	2,191	4,374	3,891	4,388	34,530	2,748
Total Gross Profit	9,405	8,927	8,032	7,006	6,301	10,326	19,308	9,498	40,090	2,730
Total Revenue	23,028	21,727	19,078	17,938	16,663	34,438	35,978	33,558	62,684	11,052
Operating Revenue	23,028	21,727	19,078	17,938	16,663	34,438	35,978	33,558	62,684	11,052
Total Cost of Revenue	13,623	12,800	11,046	10,932	10,362	24,112	16,670	24,060	22,594	8,322
Operating Cost of Revenue	13,623	12,800	11,046	10,932	10,362	24,112	16,670	24,060	22,594	8,322
Total Operating Expenses	5,086	4,904	4,717	4,324	4,110	5,952	15,417	5,110	5,560	-18
Depreciation Expense	3,594	3,506	3,325	3,033	2,891	4,252	4,353	3,828	3,936	-
Other Operating Expenses / (Income)	1,504	1,408	1,390	1,291	1,232	1,731	11,120	1,518	1,576	0.00
Other Special Charges / (Income)	-12	-10	2.00	0.00	-13	-31	-56	-236	48	-18
Total Other Income / (Expense), net	-1,652	-1,321	-912	-1,028	-1,099	-389	-1,666	-613	-1,239	-1,079
Interest Expense	1,914	1,729	1,447	1,289	1,307	1,616	1,554	1,560	1,536	-
Other Income / (Expense), net	262	408	535	261	208	1,227	-112	947	297	-
Income Tax Expense	207	374	349	38	-7.00	774	118	-126	753	-
Net Income / (Loss) Discontinued Operations	0.00	0.00	117	213	855	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	1.00	123	-9.00	92	74	90	75	-28
Weighted Average Basic Shares Outstanding	1.00B	996M	986M	979M	976M	973M	967M	947M	924M	890M
Weighted Average Diluted Shares Outstanding	1.00B	997M	987M	980M	977M	974M	969M	949M	927M	893M
Weighted Average Basic & Diluted Shares Outstanding	1.31B	1.31B	1.30B	1.29B	2.56B	973M	966.30M	946.50M	924M	890M
Cash Dividends to Common per Share	$1.52	$1.44	$1.35	$1.53	$1.53	$1.45	$1.38	$1.31	$0.00	$1.24

This table shows Exelon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	908	647	707	448	658	616	700	343	669	-	676
Consolidated Net Income / (Loss)	-7.00	647	707	448	658	616	700	343	669	-	676
Net Income / (Loss) Continuing Operations	-7.00	647	707	448	658	616	700	343	669	-	676
Total Pre-Tax Income	-7.00	695	757	494	721	716	767	416	803	-	768
Total Operating Income	0.00	1,096	1,196	913	1,114	1,090	1,123	704	1,106	-	1,011
Total Gross Profit	0.00	-1,368	3,771	3,369	3,633	-1,219	3,583	3,091	3,472	-	2,213
Total Revenue	0.00	5,470	6,154	5,361	6,043	5,366	5,980	4,818	5,563	-	4,845
Total Cost of Revenue	0.00	6,838	2,383	1,992	2,410	6,585	2,397	1,727	2,091	-	2,632
Total Operating Expenses	0.00	-2,471	2,575	2,463	2,519	-2,309	2,460	2,387	2,366	-	1,202
Total Other Income / (Expense), net	-7.00	-401	-439	-419	-393	-374	-356	-288	-303	-	-243
Interest Expense	7.00	467	496	483	468	453	437	427	412	-	365
Basic Earnings per Share	$0.90	-	$0.70	$0.45	$0.66	$0.62	$0.70	$0.34	$0.67	-	-
Weighted Average Basic Shares Outstanding	1.01B	1.00B	1.00B	1.00B	1B	996M	996M	995M	995M	986M	988M
Diluted Earnings per Share	$0.90	-	$0.70	$0.45	$0.66	$0.62	$0.70	$0.34	$0.67	-	-
Weighted Average Diluted Shares Outstanding	1.01B	1.00B	1.00B	1.00B	1.00B	997M	997M	996M	996M	987M	989M
Weighted Average Basic & Diluted Shares Outstanding	1.32B	1.31B	1.31B	1.31B	1.31B	1.31B	1.30B	1.30B	1.30B	1.30B	1.30B
Cash Dividends to Common per Share	$0.40	-	$0.38	$0.38	$0.38	$0.36	$0.36	$0.36	$0.36	$0.34	$0.34

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-162	11	-529	453	44	-659	-3,841	276	-5,798	4,624
Net Cash From Operating Activities	5,569	4,703	4,870	3,012	4,235	6,659	4,303	7,480	8,461	7,616
Net Cash From Continuing Operating Activities	5,569	4,703	4,870	3,012	5,533	5,433	4,303	6,024	8,461	7,558
Net Income / (Loss) Continuing Operations	2,460	2,328	2,171	1,829	1,954	3,028	0.00	3,869	1,196	2,250
Consolidated Net Income / (Loss)	2,460	2,328	2,171	1,829	1,954	3,028	-	3,869	1,196	2,250
Depreciation Expense	3,596	3,506	3,533	7,573	6,527	5,780	5,971	5,427	5,576	3,987
Non-Cash Adjustments To Reconcile Net Income	708	-4.00	833	-940	553	1,027	-1,217	-169	2,138	1,643
Changes in Operating Assets and Liabilities, net	-1,195	-1,127	-1,667	-5,450	-4,799	-3,176	-451	-1,647	-449	-322
Net Cash From Investing Activities	-7,042	-7,375	-6,990	-3,317	-4,336	-7,260	-7,925	-7,971	-15,450	-7,822
Net Cash From Continuing Investing Activities	-7,042	-7,375	-6,990	-3,317	-4,336	-7,260	-7,925	-7,971	-15,450	-7,822
Purchase of Property, Plant & Equipment	-7,097	-7,408	-7,147	-7,981	-8,048	-7,248	-7,594	-7,584	-8,553	-7,624
Purchase of Investments	0.00	0.00	-516	-6,673	-3,464	-10,087	-8,997	-8,113	-9,738	-7,147
Sale of Property, Plant & Equipment	38	25	16	877	46	53	-	219	61	147
Sale and/or Maturity of Investments	0.00	0.00	488	6,532	3,341	10,051	8,762	7,845	9,496	6,895
Other Investing Activities, net	17	8.00	169	3,928	3,789	12	58	-43	207	-53
Net Cash From Financing Activities	1,311	2,683	1,591	758	145	-58	-219	767	1,191	4,830
Net Cash From Continuing Financing Activities	1,311	2,683	1,591	758	145	-58	-219	767	1,183	4,830
Repayment of Debt	-2,215	-2,290	-2,689	-1,801	-6,415	-713	-1,895	-3,784	-2,836	-2,706
Payment of Dividends	-1,524	-1,433	-1,334	-2,382	-1,492	-1,408	-1,332	-1,236	-1,174	-1,105
Issuance of Debt	4,859	6,225	7,609	4,861	8,007	1,951	2,903	4,091	4,956	6,709
Issuance of Common Equity	191	181	599	80	45	112	105	1,696	427	1,932
Other Financing Activities, net	0.00	0.00	-2,594	0.00	0.00	0.00	0.00	-	0.00	0.00

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	643	-294	-302	227	207	154	-88	-48	-7.00	-183	701
Net Cash From Operating Activities	1,200	1,426	1,689	1,462	992	1,411	1,531	1,277	484	729	3,737
Net Cash From Continuing Operating Activities	1,200	1,426	1,689	1,462	992	1,411	1,531	1,277	484	729	3,737
Net Income / (Loss) Continuing Operations	908	647	707	448	658	617	699	343	669	432	1,739
Consolidated Net Income / (Loss)	908	647	707	448	658	617	699	343	669	432	-
Depreciation Expense	905	913	909	894	880	890	889	867	860	854	-
Non-Cash Adjustments To Reconcile Net Income	467	419	-20	225	84	2.00	118	-99	-25	112	278
Changes in Operating Assets and Liabilities, net	-1,080	-553	93	-105	-630	-98	-175	166	-1,020	-669	-959
Net Cash From Investing Activities	-1,942	-1,928	-1,647	-1,700	-1,767	-1,860	-1,840	-1,804	-1,871	-2,004	-5,312
Net Cash From Continuing Investing Activities	-1,942	-1,928	-1,647	-1,700	-1,767	-1,860	-1,840	-1,804	-1,871	-2,004	-5,312
Purchase of Property, Plant & Equipment	-1,946	-1,936	-1,695	-1,699	-1,767	-1,868	-1,855	-1,804	-1,881	-1,968	-
Sale of Property, Plant & Equipment	0.00	-	-	-	2.00	25	-	-	0.00	-	-
Other Investing Activities, net	4.00	8.00	10	1.00	-2.00	-17	15	-	10	-36	-133
Net Cash From Financing Activities	1,385	208	-344	465	982	603	221	479	1,380	1,092	2,276
Net Cash From Continuing Financing Activities	1,385	208	-344	465	982	603	221	479	1,380	1,092	2,276
Repayment of Debt	-810	-247	221	-766	-1,423	286	467	-846	-2,197	759	-3,098
Payment of Dividends	-403	-382	-381	-380	-381	-359	-357	-359	-358	-335	-
Issuance of Debt	2,425	827	-343	1,600	2,775	525	100	1,675	3,925	658	5,801
Issuance of Common Equity	173	10	159	11	11	151	11	9.00	10	10	572

This table presents Exelon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	107,784	101,856	95,349	133,013	129,317	124,977	119,634	116,770	114,904	95,384
Total Current Assets	8,384	8,087	7,336	13,957	12,562	12,037	13,328	11,896	12,412	15,334
Cash & Equivalents	357	445	407	672	663	587	1,349	898	635	6,502
Restricted Cash	541	482	566	321	438	358	247	207	253	205
Accounts Receivable	3,754	3,361	3,561	2,865	4,700	6,223	5,863	5,577	5,359	912
Inventories, net	853	801	755	581	1,722	1,768	1,685	1,651	1,638	1,566
Prepaid Expenses	494	413	-	-	-	-	-	-	-	-
Current Deferred & Refundable Income Taxes	0.00	0.00	-	-	0.00	0.00	0.00	0.00	1,250	0.00
Other Current Assets	2,385	2,585	2,047	1,683	4,152	3,149	3,280	3,563	3,277	2,962
Plant, Property, & Equipment, net	78,182	73,593	69,076	64,558	82,584	80,233	76,707	74,202	71,555	57,439
Total Noncurrent Assets	21,218	20,176	18,937	54,498	34,171	32,707	29,599	30,672	30,937	22,405
Long-Term Investments	290	251	232	250	440	464	625	640	629	639
Noncurrent Note & Lease Receivables	4,026	3,232	2,897	0.00	0.00	0.00	0.00	0.00	-	0.00
Goodwill	6,630	6,630	6,630	6,630	6,677	6,677	6,677	6,677	6,677	2,672
Employee Benefit Assets	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	-	-
Other Noncurrent Operating Assets	10,272	10,063	9,178	9,109	27,054	25,566	22,297	23,355	23,631	19,094
Total Liabilities & Shareholders' Equity	107,784	101,856	95,349	133,013	129,317	124,977	119,634	116,770	114,904	95,384
Total Liabilities	80,863	76,101	70,605	98,218	94,449	90,404	86,587	84,583	87,292	68,062
Total Current Liabilities	9,611	9,901	10,611	16,111	12,771	14,185	11,404	10,798	13,457	9,118
Short-Term Debt	3,312	3,926	4,388	3,401	3,850	6,080	2,063	3,017	3,697	2,033
Accounts Payable	2,999	2,851	3,387	2,384	3,567	3,565	3,805	3,889	3,441	3,193
Accrued Expenses	1,468	1,375	1,226	1,137	2,078	1,981	2,112	1,837	3,460	2,376
Customer Deposits	446	411	-	-	-	0.00	0.00	0.00	-	0.00
Other Current Liabilities	1,386	1,338	1,610	1,249	2,901	2,559	2,647	2,055	2,700	1,516
Total Noncurrent Liabilities	71,252	66,200	59,994	82,107	81,678	76,219	75,183	73,785	73,835	58,854
Long-Term Debt	43,337	40,082	35,662	30,749	35,093	31,329	34,075	32,176	31,575	23,645
Asset Retirement Reserve & Litigation Obligation	10,499	9,843	9,381	9,899	22,993	22,031	20,409	21,041	14,336	13,807
Noncurrent Deferred & Payable Income Tax Liabilities	12,793	11,956	11,250	10,611	13,035	12,351	11,321	11,235	18,138	13,776
Noncurrent Employee Benefit Liabilities	2,217	2,098	1,616	2,862	6,514	6,323	5,916	5,829	6,096	5,003
Other Noncurrent Operating Liabilities	2,406	2,221	2,085	2,310	4,043	4,185	3,462	3,504	3,049	1,982
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	26,921	25,755	24,744	34,795	34,868	34,573	33,047	32,187	27,612	27,294
Total Preferred & Common Equity	26,921	25,755	24,744	34,393	32,585	32,224	30,741	29,896	25,837	25,793
Total Common Equity	0.00	0.00	24,744	34,393	32,585	32,224	30,741	29,896	25,837	25,793
Common Stock	21,338	21,114	20,908	20,324	19,373	19,274	19,116	18,964	18,794	18,676
Retained Earnings	6,426	5,490	4,597	16,942	16,735	16,267	14,743	14,081	12,030	12,068
Treasury Stock	-123	-123	-123	-123	-123	-123	-123	-123	-2,327	-2,327
Accumulated Other Comprehensive Income / (Loss)	-720	-726	-638	-2,750	-3,400	-3,194	-2,995	-3,026	-2,660	-2,624

This table presents Exelon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	12/31/2022	9/30/2022
Total Assets	109,484	107,784	106,070	105,113	103,211	101,856	99,259	98,080	95,349	93,455
Total Current Assets	8,799	8,384	8,023	8,557	8,212	8,087	7,519	7,542	7,336	7,055
Cash & Equivalents	1,004	357	616	934	720	445	300	399	407	446
Restricted Cash	578	541	552	530	489	482	435	435	566	744
Accounts Receivable	4,016	3,754	3,660	3,709	3,585	3,361	3,314	3,125	3,561	3,430
Inventories, net	833	853	855	824	788	801	762	710	755	757
Prepaid Expenses	240	494	-	-	-	413	-	-	-	-
Current Deferred & Refundable Income Taxes	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-	0.00
Other Current Assets	2,128	2,385	2,340	2,560	2,630	2,585	2,708	2,968	2,047	1,678
Plant, Property, & Equipment, net	79,177	78,182	76,661	75,646	74,604	73,593	72,458	71,300	69,076	67,572
Total Noncurrent Assets	21,508	21,218	21,386	20,910	20,395	20,176	19,282	19,238	18,937	18,828
Long-Term Investments	289	290	279	270	263	251	246	238	232	230
Noncurrent Note & Lease Receivables	4,110	4,026	4,322	3,840	3,382	3,232	2,923	3,120	2,897	2,658
Goodwill	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630
Employee Benefit Assets	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-
Other Noncurrent Operating Assets	10,479	10,272	10,155	10,170	10,120	10,063	9,483	9,250	9,178	9,310
Total Liabilities & Shareholders' Equity	109,484	107,784	106,070	105,113	103,211	101,856	99,259	98,080	95,349	93,455
Total Liabilities	81,877	80,863	79,448	78,961	77,150	76,101	73,789	73,001	70,605	68,873
Total Current Liabilities	8,103	9,611	7,384	8,275	7,975	9,901	8,800	7,936	10,611	8,717
Short-Term Debt	2,538	3,312	1,985	2,762	2,709	3,926	3,374	2,741	4,388	2,990
Accounts Payable	2,698	2,999	2,653	2,815	2,819	2,851	2,689	0.00	3,387	2,698
Accrued Expenses	1,186	1,468	1,284	1,241	1,076	1,375	1,315	1,220	1,226	1,213
Customer Deposits	465	446	432	425	419	411	-	-	-	-
Other Current Liabilities	1,216	1,386	1,030	1,032	952	1,338	1,422	1,464	1,610	1,816
Total Noncurrent Liabilities	73,774	71,252	72,064	70,686	69,175	66,200	64,989	65,454	59,994	60,156
Long-Term Debt	45,732	43,337	44,091	43,429	42,661	40,082	39,821	40,271	35,662	35,283
Asset Retirement Reserve & Litigation Obligation	10,594	10,499	10,852	10,470	9,976	9,843	9,505	9,679	9,381	9,110
Noncurrent Deferred & Payable Income Tax Liabilities	13,081	12,793	12,551	12,358	12,199	11,956	11,792	11,547	11,250	11,113
Noncurrent Employee Benefit Liabilities	1,955	2,217	2,081	2,086	2,092	2,098	1,600	1,571	1,616	2,162
Other Noncurrent Operating Liabilities	2,412	2,406	2,489	2,343	2,247	2,221	2,271	2,386	2,085	2,488
Total Equity & Noncontrolling Interests	27,607	26,921	26,622	26,152	26,061	25,755	25,470	25,079	24,744	24,582
Total Preferred & Common Equity	27,607	26,921	26,622	26,152	26,061	25,755	25,470	25,079	24,744	24,582
Total Common Equity	27,607	0.00	26,622	26,152	26,061	0.00	25,470	25,079	24,744	24,582
Common Stock	21,517	21,338	21,320	21,152	21,129	21,114	20,956	20,941	20,908	20,895
Retained Earnings	6,931	6,426	6,161	5,835	5,767	5,490	5,233	4,891	4,597	4,502
Treasury Stock	-123	-123	-123	-123	-123	-123	-123	-123	-123	-123
Accumulated Other Comprehensive Income / (Loss)	-718	-720	-736	-712	-712	-726	-596	-630	-638	-692
Other Equity Adjustments	0.00	-	0.00	0.00	0.00	-	0.00	-	-	-

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.99%	13.89%	6.36%	7.65%	-51.61%	-4.28%	7.21%	-46.46%	467.17%	-92.15%
EBITDA Growth	3.02%	7.50%	-29.79%	17.81%	-21.57%	16.73%	-9.40%	-73.36%	499.90%	-36.89%
EBIT Growth	3.39%	15.09%	30.82%	22.68%	-57.17%	48.21%	-29.17%	-84.68%	1,167.36%	-59.61%
NOPAT Growth	14.93%	22.33%	8.13%	18.84%	-37.44%	-4.35%	-18.74%	-78.76%	676.98%	-54.54%
Net Income Growth	5.67%	7.23%	18.70%	-6.40%	-35.47%	45.65%	-46.27%	223.50%	-28.34%	-69.38%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	45.65%	-47.99%	228.93%	-52.36%	35.11%
Operating Cash Flow Growth	18.41%	-3.43%	61.69%	-28.88%	-36.40%	54.75%	-42.47%	-11.59%	11.10%	70.88%
Free Cash Flow Firm Growth	112.21%	73.54%	-129.90%	1,672.01%	615.73%	-108.52%	132.79%	-51.00%	-72.08%	213.74%
Invested Capital Growth	5.54%	7.86%	15.67%	-23.31%	1.58%	5.59%	1.83%	5.58%	44.60%	-10.51%
Revenue Q/Q Growth	0.45%	0.00%	0.00%	24.49%	-49.91%	-1.33%	1.20%	-16.78%	87.60%	-91.18%
EBITDA Q/Q Growth	0.20%	128.73%	82.39%	107.79%	3.98%	8.58%	-10.73%	-37.84%	43.58%	-54.74%
EBIT Q/Q Growth	-0.15%	0.00%	0.00%	116.40%	-43.66%	21.00%	-24.16%	-54.58%	50.94%	-74.88%
NOPAT Q/Q Growth	2.22%	0.00%	0.00%	213.88%	-29.52%	2.13%	-27.26%	-46.09%	32.19%	-64.12%
Net Income Q/Q Growth	1.28%	0.00%	0.00%	-2.51%	-16.03%	30.46%	-46.92%	78.21%	79.58%	105.32%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	30.46%	-46.79%	80.09%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.27%	16.96%	61.69%	-64.66%	-0.45%	5,992.92%	-49.27%	10.47%	-9.07%	49.04%
Free Cash Flow Firm Q/Q Growth	-43.47%	75.52%	91.14%	-74.47%	-12.54%	-125.52%	-4.76%	-82.05%	105.51%	-83.43%
Invested Capital Q/Q Growth	1.59%	1.33%	3.51%	1,544.02%	0.85%	1.98%	0.38%	2.36%	0.83%	617.49%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.84%	41.09%	42.10%	39.06%	37.81%	29.98%	53.67%	28.30%	63.96%	24.70%
EBITDA Margin	35.51%	36.53%	38.70%	58.62%	53.57%	33.05%	27.10%	32.07%	64.46%	60.94%
Operating Margin	18.76%	18.52%	17.38%	14.95%	13.15%	12.70%	10.81%	13.08%	55.09%	24.86%
EBIT Margin	19.89%	20.39%	20.18%	16.41%	14.40%	16.26%	10.50%	15.90%	55.56%	24.86%
Profit (Net Income) Margin	10.68%	10.71%	11.38%	10.20%	11.73%	8.79%	5.78%	11.53%	1.91%	15.10%
Tax Burden Percent	92.24%	86.16%	90.35%	110.58%	178.94%	75.98%	93.44%	102.49%	60.62%	50.12%
Interest Burden Percent	58.22%	60.98%	62.42%	56.20%	45.52%	71.15%	58.88%	70.76%	5.67%	121.18%
Effective Tax Rate	7.76%	13.84%	14.52%	2.30%	-0.64%	19.42%	5.30%	-3.34%	38.17%	0.00%
Return on Invested Capital (ROIC)	5.65%	5.24%	4.78%	4.14%	3.10%	5.13%	5.56%	7.10%	40.61%	6.04%
ROIC Less NNEP Spread (ROIC-NNEP)	2.20%	2.46%	2.53%	1.36%	2.41%	3.71%	0.79%	5.14%	-39.61%	0.40%
Return on Net Nonoperating Assets (RNNOA)	3.69%	3.98%	2.51%	1.11%	2.53%	3.83%	0.81%	5.84%	-36.25%	0.29%
Return on Equity (ROE)	9.34%	9.22%	7.29%	5.25%	5.63%	8.96%	6.37%	12.94%	4.36%	6.32%
Cash Return on Invested Capital (CROIC)	0.27%	-2.31%	-9.75%	30.53%	1.53%	-0.31%	3.75%	1.67%	4.14%	17.13%
Operating Return on Assets (OROA)	4.37%	4.49%	3.37%	2.24%	1.89%	4.58%	3.20%	4.61%	33.12%	3.30%
Return on Assets (ROA)	2.35%	2.36%	1.90%	1.39%	1.54%	2.48%	1.76%	3.34%	1.14%	2.00%
Return on Common Equity (ROCE)	0.00%	4.52%	7.24%	5.05%	5.25%	8.34%	5.92%	12.06%	4.10%	6.12%
Return on Equity Simple (ROE_SIMPLE)	9.14%	9.04%	8.77%	5.32%	6.00%	9.40%	6.76%	12.94%	4.63%	6.47%
Net Operating Profit after Tax (NOPAT)	3,984	3,466	2,834	2,620	2,205	3,524	3,685	4,534	21,352	2,748
NOPAT Margin	17.30%	15.95%	14.85%	14.61%	13.23%	10.23%	10.24%	13.51%	34.06%	24.86%
Net Nonoperating Expense Percent (NNEP)	3.45%	2.79%	2.25%	2.78%	0.69%	1.42%	4.78%	1.96%	80.22%	5.64%
Return On Investment Capital (ROIC_SIMPLE)	5.42%	4.97%	4.37%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	59.16%	58.91%	57.90%	60.94%	62.19%	70.02%	46.33%	71.70%	36.04%	75.30%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.09%	22.57%	24.72%	24.11%	24.67%	17.28%	42.85%	15.23%	8.87%	-0.16%
Earnings before Interest and Taxes (EBIT)	4,581	4,431	3,850	2,943	2,399	5,601	3,779	5,335	34,827	2,748
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	8,177	7,937	7,383	10,516	8,926	11,381	9,750	10,762	40,403	6,735
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	2.10	1.96	1.46	1.53	1.53	1.32	1.29	0.96
Price to Tangible Book Value (P/TBV)	0.00	0.00	2.87	2.42	1.83	1.93	1.95	1.70	1.74	1.08
Price to Revenue (P/Rev)	2.14	2.06	2.73	3.75	2.85	1.43	1.31	1.18	0.53	2.25
Price to Earnings (P/E)	20.06	19.27	23.99	39.44	24.17	16.77	23.45	10.47	29.75	14.66
Dividend Yield	4.04%	4.18%	3.37%	2.92%	4.13%	3.77%	3.74%	4.20%	4.66%	6.07%
Earnings Yield	4.99%	5.19%	4.17%	2.54%	4.14%	5.96%	4.26%	9.55%	3.36%	6.82%
Enterprise Value to Invested Capital (EV/IC)	1.31	1.28	1.43	1.83	1.22	1.24	1.25	1.15	1.11	1.04
Enterprise Value to Revenue (EV/Rev)	4.12	4.04	4.77	5.61	5.23	2.54	2.31	2.24	1.10	4.05
Enterprise Value to EBITDA (EV/EBITDA)	11.59	11.05	12.31	9.57	9.76	7.70	8.54	7.00	1.70	6.64
Enterprise Value to EBIT (EV/EBIT)	20.69	19.79	23.61	34.18	36.32	15.64	22.03	14.11	1.98	16.27
Enterprise Value to NOPAT (EV/NOPAT)	23.80	25.30	32.08	38.39	39.52	24.85	22.59	16.60	3.23	16.27
Enterprise Value to Operating Cash Flow (EV/OCF)	17.02	18.64	18.67	33.40	20.58	13.15	19.35	10.07	8.14	5.87
Enterprise Value to Free Cash Flow (EV/FCFF)	507.56	0.00	0.00	5.20	79.87	0.00	33.53	70.60	31.65	5.74
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.73	1.71	1.62	0.98	1.12	1.08	1.09	1.09	1.28	0.94
Long-Term Debt to Equity	1.61	1.56	1.44	0.88	1.01	0.91	1.03	1.00	1.14	0.87
Financial Leverage	1.68	1.62	0.99	0.82	1.05	1.03	1.03	1.14	0.92	0.72
Leverage Ratio	3.98	3.91	3.84	3.77	3.66	3.62	3.62	3.87	3.83	3.16
Compound Leverage Factor	2.32	2.38	2.39	2.12	1.67	2.57	2.13	2.74	0.22	3.83
Debt to Total Capital	63.41%	63.08%	61.81%	49.53%	52.76%	51.97%	52.23%	52.23%	56.09%	48.47%
Short-Term Debt to Total Capital	4.50%	5.63%	6.77%	4.93%	5.22%	8.45%	2.98%	4.48%	5.88%	3.84%
Long-Term Debt to Total Capital	58.91%	57.45%	55.04%	44.60%	47.54%	43.52%	49.25%	47.75%	50.21%	44.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.58%	3.09%	3.26%	3.33%	3.40%	2.82%	2.83%
Common Equity to Total Capital	0.00%	0.00%	38.19%	49.88%	44.15%	44.77%	44.43%	44.37%	41.09%	48.69%
Debt to EBITDA	5.70	5.54	5.42	3.25	4.36	3.29	3.71	3.27	0.87	3.81
Net Debt to EBITDA	5.56	5.40	5.26	3.13	4.19	3.16	3.48	3.11	0.84	2.72
Long-Term Debt to EBITDA	5.30	5.05	4.83	2.92	3.93	2.75	3.49	2.99	0.78	3.51
Debt to NOPAT	11.71	12.70	14.13	13.03	17.66	10.61	9.81	7.76	1.65	9.34
Net Debt to NOPAT	11.41	12.36	13.71	12.56	16.96	10.21	9.21	7.38	1.58	6.67
Long-Term Debt to NOPAT	10.88	11.56	12.59	11.73	15.91	8.89	9.25	7.10	1.48	8.60
Altman Z-Score	0.79	0.76	0.80	0.78	0.67	0.91	0.92	0.90	1.91	0.69
Noncontrolling Interest Sharing Ratio	100.00%	51.00%	0.68%	3.85%	6.67%	6.88%	7.05%	6.80%	5.97%	3.21%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.87	0.82	0.69	0.87	0.98	0.85	1.17	1.10	0.92	1.68
Quick Ratio	0.43	0.38	0.37	0.22	0.41	0.48	0.63	0.60	0.45	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	187	-1,530	-5,781	19,333	1,091	-212	2,483	1,066	2,177	7,795
Operating Cash Flow to CapEx	78.89%	63.70%	68.29%	42.40%	52.92%	92.55%	56.66%	101.56%	99.64%	101.86%
Free Cash Flow to Firm to Interest Expense	0.10	-0.88	-4.00	15.00	0.83	-0.13	1.60	0.68	1.42	0.00
Operating Cash Flow to Interest Expense	2.91	2.72	3.37	2.34	3.24	4.12	2.77	4.79	5.51	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.78	-1.55	-1.56	-3.17	-2.88	-0.33	-2.12	0.07	-0.02	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.22	0.17	0.14	0.13	0.28	0.30	0.29	0.60	0.13
Accounts Receivable Turnover	6.47	6.28	5.94	4.74	3.05	5.70	6.29	6.14	19.99	0.00
Inventory Turnover	16.47	16.45	16.54	9.49	5.94	13.97	9.99	14.63	14.10	5.25
Fixed Asset Turnover	0.30	0.30	0.29	0.24	0.20	0.44	0.48	0.46	0.97	0.20
Accounts Payable Turnover	4.66	4.10	3.83	3.67	2.91	6.54	4.33	6.56	6.81	4.92
Days Sales Outstanding (DSO)	56.39	58.14	61.47	76.97	119.63	64.05	58.03	59.47	18.26	0.00
Days Inventory Outstanding (DIO)	22.16	22.19	22.07	38.45	61.47	26.14	36.52	24.95	25.88	69.50
Days Payable Outstanding (DPO)	78.37	88.94	95.35	99.35	125.61	55.78	84.23	55.60	53.59	74.23
Cash Conversion Cycle (CCC)	0.18	-8.61	-11.80	16.07	55.49	34.40	10.32	28.82	-9.45	-4.74
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	72,382	68,585	63,589	54,974	71,687	70,573	66,837	65,635	62,167	42,992
Invested Capital Turnover	0.33	0.33	0.32	0.28	0.23	0.50	0.54	0.53	1.19	0.24
Increase / (Decrease) in Invested Capital	3,797	4,996	8,615	-16,713	1,114	3,736	1,202	3,468	19,175	-5,047
Enterprise Value (EV)	94,803	87,684	90,910	100,590	87,140	87,581	83,250	75,289	68,879	44,709
Market Capitalization	49,342	44,854	52,065	67,281	47,455	49,232	47,027	39,550	33,349	24,876
Book Value per Share	$0.00	$0.00	$19.04	$26.78	$25.42	$25.21	$24.15	$23.60	$21.02	$21.19
Tangible Book Value per Share	($5.06)	($5.09)	$13.94	$21.62	$20.22	$19.99	$18.90	$18.33	$15.59	$19.00
Total Capital	73,570	69,763	64,794	68,945	73,811	71,982	69,185	67,380	62,884	52,972
Total Debt	46,649	44,008	40,050	34,150	38,943	37,409	36,138	35,193	35,272	25,678
Total Long-Term Debt	43,337	40,082	35,662	30,749	35,093	31,329	34,075	32,176	31,575	23,645
Net Debt	45,461	42,830	38,845	32,907	37,402	36,000	33,917	33,448	33,755	18,332
Capital Expenditures (CapEx)	7,059	7,383	7,131	7,104	8,002	7,195	7,594	7,365	8,492	7,477
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,187	1,185	140	254	2,540	2,987	2,391	3,010	1,764	1,542
Debt-free Net Working Capital (DFNWC)	2,085	2,112	1,113	1,247	3,641	3,932	3,987	4,115	2,652	8,249
Net Working Capital (NWC)	-1,227	-1,814	-3,275	-2,154	-209	-2,148	1,924	1,098	-1,045	6,216
Net Nonoperating Expense (NNE)	1,524	1,138	663	791	251	496	1,606	665	20,156	1,079
Net Nonoperating Obligations (NNO)	45,461	42,830	38,845	20,179	36,819	36,000	33,790	33,448	34,555	15,698
Total Depreciation and Amortization (D&A)	3,596	3,506	3,533	7,573	6,527	5,780	5,971	5,427	5,576	3,987
Debt-free, Cash-free Net Working Capital to Revenue	5.15%	5.45%	0.73%	1.42%	15.24%	8.67%	6.65%	8.97%	2.81%	13.95%
Debt-free Net Working Capital to Revenue	9.05%	9.72%	5.83%	6.95%	21.85%	11.42%	11.08%	12.26%	4.23%	74.64%
Net Working Capital to Revenue	-5.33%	-8.35%	-17.17%	-12.01%	-1.25%	-6.24%	5.35%	3.27%	-1.67%	56.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$1.74	$1.43	$2.15	$1.48	$2.83	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	1.00B	996M	986M	979M	1.37B	1.37B	1.36B	1.33B	1.30B	1.25B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$1.74	$1.43	$2.14	$1.47	$2.83	$0.87	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	1.00B	997M	987M	980M	1.37B	1.37B	1.36B	1.33B	1.30B	1.25B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.31B	1.31B	1.30B	1.29B	3.60B	0.00	1.79B	2.14B	2.09B	1.25B
Normalized Net Operating Profit after Tax (NOPAT)	3,973	3,458	2,835	2,620	1,525	3,499	3,632	2,906	21,381	1,911
Normalized NOPAT Margin	17.25%	15.91%	14.86%	14.61%	9.15%	10.16%	10.09%	8.66%	34.11%	17.29%
Pre Tax Income Margin	11.58%	12.44%	12.60%	9.22%	6.55%	11.57%	6.18%	11.25%	3.15%	30.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.39	2.56	2.66	2.28	1.84	3.47	2.43	3.42	22.67	0.00
NOPAT to Interest Expense	2.08	2.00	1.96	2.03	1.69	2.18	2.37	2.91	13.90	0.00
EBIT Less CapEx to Interest Expense	-1.29	-1.71	-2.27	-3.23	-4.29	-0.99	-2.46	-1.30	17.15	0.00
NOPAT Less CapEx to Interest Expense	-1.61	-2.27	-2.97	-3.48	-4.44	-2.27	-2.52	-1.81	8.37	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	61.95%	61.56%	61.45%	130.24%	76.36%	46.50%	64.07%	31.95%	98.16%	66.21%
Augmented Payout Ratio	61.95%	61.56%	61.45%	130.24%	76.36%	46.50%	64.07%	31.95%	98.16%	66.21%

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	1.94%	2.91%	11.27%	8.63%	0.00%	23.43%	0.00%	0.00%	0.00%	-0.37%
EBITDA Growth	2.84%	0.78%	3.30%	9.42%	-0.29%	141.10%	6.89%	0.00%	0.00%	-65.07%	-31.06%
EBIT Growth	0.00%	-0.60%	4.07%	15.90%	-2.14%	0.00%	6.27%	0.00%	0.00%	-100.00%	38.85%
NOPAT Growth	0.00%	8.80%	8.99%	42.64%	10.33%	0.00%	15.17%	0.00%	0.00%	-100.00%	26.73%
Net Income Growth	-16.67%	5.03%	1.00%	30.61%	-1.64%	0.00%	3.55%	2,958.33%	0.00%	0.00%	-45.00%
EPS Growth	36.36%	0.00%	0.00%	32.35%	-1.49%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	20.97%	1.06%	10.32%	14.49%	104.96%	93.55%	-59.03%	0.00%	0.00%	164.57%	24.44%
Free Cash Flow Firm Growth	94.22%	31.58%	53.10%	99.08%	0.00%	52.89%	91.88%	-194.33%	0.00%	-146.59%	-185.13%
Invested Capital Growth	5.78%	5.54%	5.27%	2.11%	0.00%	7.86%	10.17%	0.00%	0.00%	15.67%	1,713.74%
Revenue Q/Q Growth	-100.00%	-11.11%	14.79%	-11.29%	12.62%	-10.27%	24.12%	-13.39%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-56.39%	-4.02%	15.55%	-9.57%	0.49%	-1.62%	22.40%	-17.59%	142.97%	-56.38%	0.00%
EBIT Q/Q Growth	-100.00%	-7.26%	28.25%	-17.83%	1.71%	-2.91%	42.82%	-30.62%	0.00%	-100.00%	0.00%
NOPAT Q/Q Growth	-100.00%	-8.66%	34.91%	-18.56%	8.41%	-8.50%	76.57%	-37.00%	0.00%	-100.00%	0.00%
Net Income Q/Q Growth	-101.08%	-8.49%	57.81%	-31.91%	6.82%	-12.00%	104.08%	-48.73%	0.00%	0.00%	5,733.33%
EPS Q/Q Growth	0.00%	0.00%	55.56%	-31.82%	6.45%	-11.43%	105.88%	-49.25%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-15.85%	-15.57%	15.53%	47.38%	-29.70%	-7.84%	19.89%	163.84%	-33.61%	-80.49%	0.00%
Free Cash Flow Firm Q/Q Growth	-45.75%	-13.33%	-287.65%	99.08%	-1,598.83%	22.32%	92.38%	0.00%	100.00%	86.61%	-188.53%
Invested Capital Q/Q Growth	2.24%	1.59%	0.91%	0.93%	2.00%	1.33%	-2.12%	0.00%	-100.00%	3.51%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	-25.01%	61.28%	62.84%	60.12%	-22.72%	59.92%	64.16%	62.41%	0.00%	45.68%
EBITDA Margin	0.00%	37.93%	35.13%	34.90%	34.24%	38.37%	35.00%	35.49%	37.30%	0.00%	40.41%
Operating Margin	0.00%	20.04%	19.43%	17.03%	18.43%	20.31%	18.78%	14.61%	19.88%	0.00%	20.87%
EBIT Margin	0.00%	21.24%	20.36%	18.22%	19.68%	21.79%	20.13%	17.50%	21.84%	0.00%	23.38%
Profit (Net Income) Margin	0.00%	11.83%	11.49%	8.36%	10.89%	11.48%	11.71%	7.12%	12.03%	0.00%	13.95%
Tax Burden Percent	100.00%	93.09%	93.40%	90.69%	91.26%	86.03%	91.26%	82.45%	83.31%	0.00%	88.02%
Interest Burden Percent	0.00%	59.81%	60.42%	50.56%	60.64%	61.25%	63.70%	49.35%	66.09%	0.00%	67.78%
Effective Tax Rate	0.00%	6.91%	6.61%	9.31%	8.74%	13.97%	8.74%	17.55%	16.69%	0.00%	11.98%
Return on Invested Capital (ROIC)	0.00%	6.09%	5.99%	5.03%	10.68%	5.75%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	5.25%	5.05%	4.17%	9.05%	4.96%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	8.80%	8.41%	7.21%	15.24%	8.02%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	14.89%	14.40%	12.23%	25.92%	13.76%	0.00%	0.00%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	0.38%	0.27%	0.48%	3.36%	-189.81%	-2.31%	-9.68%	-200.00%	0.00%	-9.75%	-106.20%
Operating Return on Assets (OROA)	0.00%	4.67%	4.55%	4.08%	8.47%	4.80%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	2.60%	2.57%	1.87%	4.69%	2.53%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	0.00%	0.00%	14.40%	12.23%	25.92%	6.74%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	8.91%	0.00%	9.12%	9.26%	8.89%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	0.00	1,020	1,117	828	1,017	938	1,025	580	921	0.00	890
NOPAT Margin	0.00%	18.65%	18.15%	15.44%	16.82%	17.48%	17.14%	12.05%	16.56%	0.00%	18.37%
Net Nonoperating Expense Percent (NNEP)	0.02%	0.85%	0.94%	0.86%	1.63%	0.79%	0.82%	1.08%	0.00%	0.00%	1.31%
Return On Investment Capital (ROIC_SIMPLE)	0.00%	1.39%	-	-	-	1.34%	-	-	-	0.00%	-
Cost of Revenue to Revenue	0.00%	125.01%	38.72%	37.16%	39.88%	122.72%	40.08%	35.84%	37.59%	0.00%	54.32%
SG&A Expenses to Revenue	0.00%	0.00%	20.72%	22.55%	21.03%	0.00%	19.85%	24.84%	20.69%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	-45.17%	41.84%	45.94%	41.68%	-43.03%	41.14%	49.54%	42.53%	0.00%	24.81%
Earnings before Interest and Taxes (EBIT)	0.00	1,162	1,253	977	1,189	1,169	1,204	843	1,215	0.00	1,133
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	905	2,075	2,162	1,871	2,069	2,059	2,093	1,710	2,075	854	1,958
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.19	0.00	1.99	1.71	1.84	0.00	1.85	2.01	0.00	2.10	1.82
Price to Tangible Book Value (P/TBV)	2.88	0.00	2.65	2.29	2.47	0.00	2.51	2.73	0.00	2.87	2.49
Price to Revenue (P/Rev)	2.62	2.14	2.31	1.97	2.16	2.06	0.00	0.00	0.00	2.73	0.00
Price to Earnings (P/E)	22.30	20.06	21.81	18.47	20.68	19.27	0.00	0.00	0.00	23.99	0.00
Dividend Yield	3.34%	4.04%	3.70%	4.32%	3.97%	4.18%	3.90%	3.60%	3.47%	3.37%	3.70%
Earnings Yield	4.49%	4.99%	4.58%	5.41%	4.84%	5.19%	0.00%	0.00%	0.00%	4.17%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.44	1.31	1.37	1.26	1.31	1.28	1.32	1.34	0.00	1.43	1.33
Enterprise Value to Revenue (EV/Rev)	4.64	4.12	4.26	3.92	4.13	4.04	0.00	0.00	0.00	4.77	0.00
Enterprise Value to EBITDA (EV/EBITDA)	13.45	11.59	11.96	11.02	11.58	11.05	25.78	0.00	0.00	12.31	20.15
Enterprise Value to EBIT (EV/EBIT)	24.73	20.69	21.27	19.65	20.84	19.79	0.00	0.00	0.00	23.61	0.00
Enterprise Value to NOPAT (EV/NOPAT)	24.73	23.80	25.04	23.44	25.76	25.30	0.00	0.00	0.00	32.08	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	18.49	17.02	17.57	16.53	17.62	18.64	22.25	14.83	0.00	18.67	27.08
Enterprise Value to Free Cash Flow (EV/FCFF)	392.73	507.56	295.41	38.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.75	1.73	1.73	1.77	1.74	1.71	1.70	1.72	0.00	1.62	1.56
Long-Term Debt to Equity	1.66	1.61	1.66	1.66	1.64	1.56	1.56	1.61	0.00	1.44	1.44
Financial Leverage	1.68	1.68	1.67	1.73	1.68	1.62	1.58	1.76	0.00	0.99	1.32
Leverage Ratio	3.96	3.98	3.94	3.97	3.96	3.91	3.85	3.91	0.00	3.84	3.76
Compound Leverage Factor	0.00	2.38	2.38	2.01	2.40	2.39	2.45	1.93	0.00	0.00	2.55
Debt to Total Capital	63.62%	63.41%	63.38%	63.85%	63.52%	63.08%	62.91%	63.17%	0.00%	61.81%	60.89%
Short-Term Debt to Total Capital	3.34%	4.50%	2.73%	3.82%	3.79%	5.63%	4.91%	4.03%	0.00%	6.77%	4.76%
Long-Term Debt to Total Capital	60.27%	58.91%	60.65%	60.03%	59.72%	57.45%	57.99%	59.14%	0.00%	55.04%	56.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	36.38%	0.00%	36.62%	36.15%	36.48%	0.00%	37.09%	36.83%	0.00%	38.19%	39.11%
Debt to EBITDA	6.08	5.70	5.65	5.71	5.72	5.54	12.45	0.00	0.00	5.42	9.45
Net Debt to EBITDA	5.84	5.56	5.47	5.49	5.54	5.40	12.17	0.00	0.00	5.26	9.10
Long-Term Debt to EBITDA	5.76	5.30	5.40	5.37	5.38	5.05	11.48	0.00	0.00	4.83	8.72
Debt to NOPAT	11.18	11.71	11.82	12.14	12.73	12.70	0.00	0.00	0.00	14.13	0.00
Net Debt to NOPAT	10.74	11.41	11.45	11.68	12.31	12.36	0.00	0.00	0.00	13.71	0.00
Long-Term Debt to NOPAT	10.59	10.88	11.31	11.41	11.97	11.56	0.00	0.00	0.00	12.59	0.00
Altman Z-Score	0.75	0.69	0.74	0.67	0.71	0.66	0.48	0.51	0.00	0.67	0.48
Noncontrolling Interest Sharing Ratio	0.00%	100.00%	0.00%	0.00%	0.00%	51.00%	0.00%	0.00%	0.00%	0.00%	1.64%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	0.87	1.09	1.03	1.03	0.82	0.85	0.95	0.00	0.69	0.81
Quick Ratio	0.62	0.43	0.58	0.56	0.54	0.38	0.41	0.43	0.00	0.37	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,047	-2,777	-2,450	-632	-68,942	-4,058	-5,224	-68,569	0.00	-8,615	-64,352
Operating Cash Flow to CapEx	61.67%	73.66%	99.65%	86.05%	56.20%	76.56%	82.53%	70.79%	25.73%	37.04%	0.00%
Free Cash Flow to Firm to Interest Expense	-578.14	-5.95	-4.94	-1.31	-147.31	-8.96	-11.95	-160.58	0.00	0.00	-176.31
Operating Cash Flow to Interest Expense	171.43	3.05	3.41	3.03	2.12	3.11	3.50	2.99	1.17	0.00	10.24
Operating Cash Flow Less CapEx to Interest Expense	-106.57	-1.09	-0.01	-0.49	-1.65	-0.95	-0.74	-1.23	-3.39	0.00	10.24
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.22	0.22	0.22	0.43	0.22	0.00	0.00	0.00	0.17	0.00
Accounts Receivable Turnover	6.06	6.47	6.57	6.66	0.00	6.28	0.00	0.00	0.00	5.94	0.00
Inventory Turnover	16.81	16.47	16.54	17.45	0.00	16.45	0.00	0.00	0.00	16.54	0.00
Fixed Asset Turnover	0.30	0.30	0.31	0.31	0.00	0.30	0.00	0.00	0.00	0.29	0.00
Accounts Payable Turnover	4.94	4.66	5.01	0.00	0.00	4.10	0.00	0.00	0.00	3.83	0.00
Days Sales Outstanding (DSO)	60.24	56.39	55.52	54.82	0.00	58.14	0.00	0.00	0.00	61.47	0.00
Days Inventory Outstanding (DIO)	21.72	22.16	22.07	20.92	0.00	22.19	0.00	0.00	0.00	22.07	0.00
Days Payable Outstanding (DPO)	73.91	78.37	72.92	0.00	0.00	88.94	0.00	0.00	0.00	95.35	0.00
Cash Conversion Cycle (CCC)	8.05	0.18	4.67	75.74	0.00	-8.61	0.00	0.00	0.00	-11.80	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,006	72,382	71,251	70,609	69,959	68,585	67,684	69,149	0.00	63,589	61,435
Invested Capital Turnover	0.32	0.33	0.33	0.33	0.63	0.33	0.00	0.00	0.00	0.32	0.00
Increase / (Decrease) in Invested Capital	4,047	3,797	3,567	1,460	69,959	4,996	6,249	69,149	0.00	8,615	65,242
Enterprise Value (EV)	106,822	94,803	97,609	89,202	91,819	87,684	89,454	92,373	51,417	90,910	81,557
Market Capitalization	60,423	49,342	52,980	44,745	47,921	44,854	47,240	50,433	51,417	52,065	44,704
Book Value per Share	$21.05	$0.00	$20.38	$20.02	$26.06	$0.00	$19.57	$25.21	$0.00	$19.04	$19.11
Tangible Book Value per Share	$16.00	($5.06)	$15.30	$14.95	$19.43	($5.09)	$14.48	$18.54	$0.00	$13.94	$13.96
Total Capital	75,877	73,570	72,698	72,343	71,431	69,763	68,665	68,091	0.00	64,794	62,855
Total Debt	48,270	46,649	46,076	46,191	45,370	44,008	43,195	43,012	0.00	40,050	38,273
Total Long-Term Debt	45,732	43,337	44,091	43,429	42,661	40,082	39,821	40,271	0.00	35,662	35,283
Net Debt	46,399	45,461	44,629	44,457	43,898	42,830	42,214	41,940	0.00	38,845	36,853
Capital Expenditures (CapEx)	1,946	1,936	1,695	1,699	1,765	1,843	1,855	1,804	1,881	1,968	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,652	1,187	1,456	1,580	1,737	1,185	1,358	1,513	0.00	140	138
Debt-free Net Working Capital (DFNWC)	3,234	2,085	2,624	3,044	2,946	2,112	2,093	2,347	0.00	1,113	1,328
Net Working Capital (NWC)	696	-1,227	639	282	237	-1,814	-1,281	-394	0.00	-3,275	-1,662
Net Nonoperating Expense (NNE)	7.00	373	410	380	359	322	325	237	252	0.00	214
Net Nonoperating Obligations (NNO)	46,399	45,461	44,629	44,457	43,898	42,830	42,214	44,070	0.00	38,845	36,853
Total Depreciation and Amortization (D&A)	905	913	909	894	880	890	889	867	860	854	825
Debt-free, Cash-free Net Working Capital to Revenue	7.17%	5.15%	6.35%	6.95%	7.82%	5.45%	0.00%	0.00%	0.00%	0.73%	0.00%
Debt-free Net Working Capital to Revenue	14.04%	9.05%	11.45%	13.38%	13.27%	9.72%	0.00%	0.00%	0.00%	5.83%	0.00%
Net Working Capital to Revenue	3.02%	-5.33%	2.79%	1.24%	1.07%	-8.35%	0.00%	0.00%	0.00%	-17.17%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.90	$0.00	$0.70	$0.45	$0.66	$0.62	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	1.01B	1.00B	1.00B	1.00B	1B	996M	996M	995M	995M	986M	988M
Adjusted Diluted Earnings per Share	$0.90	$0.00	$0.70	$0.45	$0.66	$0.62	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	1.01B	1.00B	1.00B	1.00B	1.00B	997M	997M	996M	996M	987M	989M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.62	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.32B	1.31B	1.31B	1.31B	1.31B	1.31B	1.30B	1.30B	1.30B	1.30B	1.30B
Normalized Net Operating Profit after Tax (NOPAT)	0.00	1,020	1,114	828	1,015	938	1,025	580	921	0.00	890
Normalized NOPAT Margin	0.00%	18.65%	18.11%	15.44%	16.79%	17.48%	17.14%	12.05%	16.56%	0.00%	18.37%
Pre Tax Income Margin	0.00%	12.71%	12.30%	9.21%	11.93%	13.34%	12.83%	8.63%	14.43%	0.00%	15.85%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	2.49	2.53	2.02	2.54	2.58	2.76	1.97	2.95	0.00	3.10
NOPAT to Interest Expense	0.00	2.18	2.25	1.71	2.17	2.07	2.35	1.36	2.24	0.00	2.44
EBIT Less CapEx to Interest Expense	-278.00	-1.66	-0.89	-1.49	-1.23	-1.49	-1.49	-2.25	-1.62	0.00	3.10
NOPAT Less CapEx to Interest Expense	-278.00	-1.96	-1.17	-1.80	-1.60	-2.00	-1.90	-2.87	-2.33	0.00	2.44
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	62.87%	61.95%	61.80%	60.98%	62.84%	61.56%	0.00%	0.00%	0.00%	61.45%	0.00%
Augmented Payout Ratio	62.87%	61.95%	61.80%	60.98%	62.84%	61.56%	0.00%	0.00%	0.00%	61.45%	0.00%

Frequently Asked Questions About Exelon's Financials

When does Exelon's fiscal year end?

According to the most recent income statement we have on file, Exelon's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Exelon's net income changed over the last 9 years?

Exelon's net income were at $2.46 billion at the end of 2024, a 5.7% increase from 2023, and a 47.4% increase since 2015. View Exelon's forecast to see where analysts expect Exelon to go next.

What is Exelon's operating income?

Exelon's total operating income in 2024 was $4.32 billion, based on the following breakdown:

Total Gross Profit: $9.41 billion
Total Operating Expenses: $5.09 billion

How has Exelon revenue changed over the last 9 years?

Over the last 9 years, Exelon's total revenue changed from $11.05 billion in 2015 to $23.03 billion in 2024, a change of 108.4%.

How much debt does Exelon have?

Exelon's total liabilities were at $80.86 billion at the end of 2024, a 6.3% increase from 2023, and a 18.8% increase since 2015.

How much cash does Exelon have?

In the past 9 years, Exelon's cash and equivalents has ranged from $357 million in 2024 to $6.50 billion in 2015, and is currently $357 million as of their latest financial filing in 2024.

How has Exelon's book value per share changed over the last 9 years?

Over the last 9 years, Exelon's book value per share changed from 21.19 in 2015 to 0.00 in 2024, a change of -100.0%.

Related Companies

This page (NASDAQ:EXC) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelon (EXC) Financials

Frequently Asked Questions About Exelon's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exelon (EXC) Financials

Annual Income Statements for Exelon

Quarterly Income Statements for Exelon

Annual Cash Flow Statements for Exelon

Quarterly Cash Flow Statements for Exelon

Annual Balance Sheets for Exelon

Quarterly Balance Sheets for Exelon

Annual Metrics And Ratios for Exelon

Quarterly Metrics And Ratios for Exelon

Frequently Asked Questions About Exelon's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools